Consolidated Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses
Research and development	$ 27.5	$ 10.1
General and administrative	37.8	6.6
Other warrant expense	0.0	78.2
Total operating expenses	65.3	94.9
Loss from operations	(65.3)	(94.9)
Other income, net	6.5	0.0
Interest expense, net	(0.4)	0.0
Loss before income taxes	(59.2)	(94.9)
Net loss	(59.2)	(94.9)
Comprehensive loss	$ (59.2)	$ (94.9)
Net loss per share, basic (in dollars per share)	$ (0.25)	$ (1.70)
Net loss per share, diluted (in dollars per share)	$ (0.25)	$ (1.70)
Weighted-average shares outstanding, basic (in shares)	239,802,805	55,796,898
Weighted-average shares outstanding, diluted (in shares)	239,802,805	55,796,898